Growth Metrics

Immuron (IMRN) Total Non-Current Liabilities (2019 - 2025)

Immuron's quarterly Total Non-Current Liabilities came in at $945.77 in Q3 2025, down 33.18% year-on-year from $1415.5 in Q3 2024, and down 98.44% quarter-over-quarter from $60570.3 in Q2 2025.

Immuron has reported Total Non-Current Liabilities for 7 years, with the latest figure at $945.77 in Q3 2025.

  • For the quarter ending Q3 2025, Total Non-Current Liabilities fell 33.18% year-over-year to $945.77; the trailing twelve-month figure through Sep 2025 stood at $945.77 (down 33.18% YoY), and the FY2025 full-year result was $945.77, down 33.18% from the prior year.
  • Total Non-Current Liabilities for Q3 2025 stood at $945.77, down from $60570.3 in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $122009.9 in Q3 2022, with the low at $361.96 in Q2 2021.
  • Average Total Non-Current Liabilities over 5 years is $49446.0, with a median of $43469.5 recorded in 2025.
  • Year-over-year, Total Non-Current Liabilities surged 7980.91% in 2021 and tumbled 99.25% in 2023.
  • Tracing IMRN's Total Non-Current Liabilities over 5 years: stood at $26368.8 in 2021, then jumped by 337.15% to $115272.5 in 2022, then plunged by 99.25% to $860.99 in 2023, then surged by 7609.97% to $66381.8 in 2024, then tumbled by 98.58% to $945.77 in 2025.
  • The last three Total Non-Current Liabilities figures came in at $945.77 (Q3 2025), $60570.3 (Q2 2025), and $66381.8 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 11.03 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 42,980.09
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 95.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 110.28 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 5.87 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 7.32 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.05 Bn
10 Immuron 1.27 Bn 1.27 Bn - 945.77

Historic Data

Download Data 🔒
DateValue
Sep 2, 2025 945.77
Jun 30, 2025 60,570.25
Dec 31, 2024 66,381.83
Sep 9, 2024 1,415.46
Jun 30, 2024 93,282.28
Dec 31, 2023 860.99
Sep 28, 2023 99,768.61
Aug 30, 2023 1,522.07
Jun 30, 2023 101,729.14
Dec 31, 2022 115,272.50
Aug 31, 2022 122,009.86
Jun 30, 2022 1,754.47
Dec 31, 2021 26,368.81
Jun 30, 2021 361.96
Dec 31, 2020 326.31
Sep 1, 2020 41,839.00
Jun 30, 2020 27,422.14
Dec 31, 2019 418.39
Jun 30, 2019 10,493.07